Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Loss and Comprehensive Loss (Unaudited)

v3.10.0.1
Consolidated Statements of Loss and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
EXPENSES        
Research and development $ 1,541 $ 825 $ 3,787 $ 948
General and administrative 1,753 1,550 5,317 1,902
Total operating expenses 3,294 2,375 9,104 2,850
OTHER INCOME (EXPENSE)        
Interest income 61 9 88 9
Bargain purchase gain [note 2]   1,272   1,272
Contingent value rights recovery [note 2]   200   200
Change in value of warrant liability   111   111
Loss on disposition of intangible asset [note 4]   (8,610)   (8,610)
Other expenses (7) (7) (34) (26)
Total other income (expense) 54 (7,025) 54 (7,044)
Net loss before income taxes (3,240) (9,400) (9,050) (9,894)
Recovery of deferred income taxes [note 4]   2,928   3,051
Net loss (3,240) (6,472) (9,050) (6,843)
OTHER COMPREHENSIVE LOSS        
Comprehensive loss $ (3,240) $ (6,472) $ (9,050) $ (6,843)
Basic and diluted net loss per common share $ (0.71) $ (8.96) $ (3.70) $ (28.10)
Shares used in computation of basic and diluted net loss per common share 4,533,943 722,583 2,448,962 243,510